Change in substantial holding

Jul 29, 2026 at 9:02 PM EDT · Issued by Nexalis Therapeutics Limited via ASX

Filed with ASX · Jul 29, 2026 at 9:02 PM EDT

On 6ix: 6ix.com/news/change-in-substantial-holding-1010

604 page 1/2 15 July 2018 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company/registered scheme/notified foreign passport fund name ACN/ARSN/APFRN NFPFRN (if applicable) 1. Details of substantial holder (1) Name...

View Attachment

6ix hasn’t read this filing yet.

Nexalis Therapeutics Limited on 6ix

Earlier from Nexalis Therapeutics

Update on Funding Facility and Clinical ProgramJul 5
Binding Letter of Intent to replace existing $53m facilityMay 27
Suspension from QuotationMay 25
Mar26 Appendix 4C Cash Flow ReportApr 30
Significant Milestone - First Patient Screened IRX-211 Ph2Apr 20

Later from Nexalis Therapeutics

Jun26 Quarterly Activities ReportJul 30
Jun26 Appendix 4C Cash Flow ReportJul 30
Half Yearly Report and AccountsAug 31
Removal of draft wording in the directors report HY accountsSep 1
Chair Appointment/ResignationOct 1

All Nexalis Therapeutics news releases

Follow Nexalis Therapeutics into a list and get an email when it puts out news.

Follow Nexalis Therapeutics